Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-masked, Parallel, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of SJP-0132 Eye Drops Compared With Placebo in Chinese Patients With Dry Eye Disease

NCT06717152 is registered in ClinicalTrials.gov with Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. as lead sponsor.

NCT NCT06717152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-masked, Parallel, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of SJP-0132 Eye Drops Compared With Placebo in Chinese Patients With Dry Eye Disease
Lead sponsor
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
December 30, 2024
Completion date
September 1, 2025
Enrollment
427 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye